| ●Editorial | Fukushima M | 5-7 | Full text | |
| ●Frontier of Clinical Medicine as Predictive Science Organized by：Learning Health Society Institute & 21st Century Medical Research Institute | 9-89 | Abstract | ||
| Opening remarks | Fukushima M | 12-4 | ||
| Introductory Lecture | Sankai Y | 15-29 | ||
| Lecture 1 | Kimura Y | 30-41 | ||
| Lecture 2 | Kawakami E | 42-60 | ||
| Lecture 3 | Sakurada K | 61-81 | ||
| Designated remarks | Teramukai S | 82-5 | ||
| Closing remarks | Fukushima M | 86-9 | ||
| ●Article | ||||
| Consideration for Approving Associations between COVID-19 Vaccines and Adverse Events by the Ministry of Health, Labour and Welfare in Japan |
Suzumura Y | 91-101 | Full text | |
| ●A Symposium on Clinical Trials in Ukraine and Bioethics | 103-52 | Full text | ||
| Opening remarks ・Opening Remarks and instructions ・Welcome Address ・Remarks from Drug Information Association | Kurihara C Kagawa C Granville CA | 105-9 | ||
| The current issues of the ethical review system in Ukraine in the context of Russian invasion | Dobrova V | 110-23 | ||
| ARENSIA Research Clinic in Kyiv: Operation from Day 0 of War | Levenko E | 124-35 | ||
| Clinical trials under the Air Raid Alert accompaniment | Patsko V | 136-42 | ||
| Comments from International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) and Ukraine Clinical Research Support Initiative (UCRSI) ・The effect of Ukraine war on international drug development ・Introduction of the collaborative activities with IFAPP Ethics WG ・Ethics, clinical research, situationally adaptive clinical trials, and open science: Learning from the Ukraine crisis | Kerpel-Fronius S Matsuyama K Crawley FP | 143-52 | ||
| ・Additional comment by organizer | Kurihara C | |||
| ●Forum | ||||
| Legal bases of inter-hospital patient transfers using ambulances in Japan: Need for radical revision of the system of law on emergency medicine |
Saio T | 153-64 | Full text | |
| Some comments on Dr. Tsubaki’s reanalysis paper of the Nagoya cervical cancer immunization survey data |
Morikawa T | 165-72 | Full text | |
| ●Instructions for authors［Japanese］＆［English］ | 173-81 | Full text | ||
| ●Editor’s note | Kurihara C | 183 | Full text | |